Our reasons for converting to valproic acid treatment in female patients with genetic generalized epilepsy: a retrospective, single-centre study.

Dilara Mermi Dibekİbrahim ÖzturaBarış Baklan

Published in: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology (2021)

VPA treatment is not used as the first choice in females of reproductive age; however, some patients will only achieve seizure control with valproate, especially those with myoclonic seizures and JAE.

Keyphrases

end stage renal disease
ejection fraction
chronic kidney disease
prognostic factors
patient reported outcomes
copy number